MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (23)
2023
-
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools
Journal of the National Cancer Institute, Vol. 115, Núm. 9, pp. 1050-1059
2022
-
Obesity is Associated With Increased Risk of Crohn's disease, but not Ulcerative Colitis: A Pooled Analysis of Five Prospective Cohort Studies
Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 5, pp. 1048-1058
2020
-
A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study
European Journal of Nutrition, Vol. 59, Núm. 7, pp. 2929-2937
2019
-
Educational note: Paradoxical collider effect in the analysis of non-communicable disease epidemiological data: A reproducible illustration and web application
International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 640-653
-
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium
International Journal of Cancer, Vol. 145, Núm. 1, pp. 58-69
-
Secular trends in stillbirth by maternal socioeconomic status in Spain 2007-15: A population-based study of 4 million births
European Journal of Public Health, Vol. 29, Núm. 6, pp. 1043-1048
2018
-
Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort
Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 790-804
-
Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort
International Journal of Cancer, Vol. 142, Núm. 7, pp. 1355-1360
-
Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation
International Journal of Cancer, Vol. 143, Núm. 3, pp. 515-526
2017
-
Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort
Journal of Ovarian Research, Vol. 10, Núm. 1, pp. 1-14
-
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women
Fertility and Sterility, Vol. 107, Núm. 4, pp. 1012-1022.e2
-
Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity
Scientific Reports, Vol. 7, Núm. 1
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341
-
A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort
Clinical Cancer Research, Vol. 22, Núm. 18, pp. 4664-4675
-
Cross-cancer genome-wide analysis of lung, ovary, breast, prostate, and colorectal cancer reveals novel pleiotropic associations
Cancer Research, Vol. 76, Núm. 17, pp. 5103-5114
-
Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study
American Journal of Clinical Nutrition, Vol. 103, Núm. 1, pp. 161-167
2015
-
Association of breast cancer risk loci with breast cancer survival
International Journal of Cancer, Vol. 137, Núm. 12, pp. 2837-2845
-
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
American Journal of Human Genetics, Vol. 97, Núm. 4, pp. 576-592
-
Rare coding variants and X-linked loci associated with age at menarche
Nature Communications, Vol. 6
2013
-
Plasma carotenoid- and retinol-weighted multi-snp scores and risk of breast cancer in the national cancer institute breast and prostate cancer cohort consortium
Cancer Epidemiology Biomarkers and Prevention, Vol. 22, Núm. 5, pp. 927-936